M&A Deal Summary

Sheridan Capital Partners Acquires The Laser Spine Institute

On September 30, 2014, private equity firm Sheridan Capital Partners acquired healthcare services company The Laser Spine Institute

Acquisition Highlights
  • This is Sheridan Capital Partners’ 1st transaction in the Healthcare Services sector.
  • This is Sheridan Capital Partners’ 3rd transaction in the United States.
  • This is Sheridan Capital Partners’ 1st transaction in Florida.
Investment Fate
  • The Laser Spine Institute was sold to a financial buyer in 2019.

M&A Deal Summary

Date 2014-09-30
Target The Laser Spine Institute
Sector Healthcare Services
Buyer(s) Sheridan Capital Partners
Deal Type Recapitalization

Target

The Laser Spine Institute

Tampa, Florida, United States
The Laser Spine Institute is an orthopedic clinic providing spinal surgery and arthroscopic spinal procedures.

Search 202,341 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer
DESCRIPTION

Sheridan Capital Partners is a private equity firm focused on acquiring and investing in consumer products/services and healthcare companies across the US and Canada. Sheridan looks to invest $15 to $100 million in businesses valued from $25 to $150 million. Prospective transaction situations include growth buyouts, family owned company acquisitions, consolidations, and recapitalizations. Sheridan Capital Partners was formed in 2012 and is headquartered in Chicago, Illinois.


DEAL STATS #
Overall 3 of 20
Sector (Healthcare Services) 1 of 9
Type (Recapitalization) 2 of 3
State (Florida) 1 of 3
Country (United States) 3 of 19
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-30 Progenicare

Austin, Texas, United States

Progenicare is a provider of autologous stem cell therapies to orthopedic surgeons and hospitals across the Western U.S. Progenicare was founded in 2008 and is based in Austin, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-10 Diamondback Drugs

Scottsdale, Arizona, United States

Diamondback Drugs LLC is a veterinary compounding pharmacy that distributes pharmaceutical products to individual pet owners, veterinary offices and clinics. The company's compounding facility allows Diamondback to provide a broad veterinary compounded pharmaceutical offering, ranging from anti-infectives and ophthalmic preparations to cancer treatment solutions. Diamondback has grown from a small veterinary compounder into a growing platform serving pets in 50 states, as well as Canada and Mexico.

Sell -